Affinity DataKi: 1.50E+3nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 2.80E+3nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 5.30E+3nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 5.80E+3nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 6.00E+3nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 6.80E+3nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 7.50E+3nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 9.40E+3nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 1.16E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 1.20E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 1.58E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 1.59E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 1.86E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 2.05E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 2.21E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 2.86E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 3.30E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 4.07E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 4.13E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 4.37E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 4.74E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 5.10E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 6.14E+4nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 1.09E+5nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 1.13E+5nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 1.15E+5nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 1.38E+5nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: 1.93E+5nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: >5.00E+5nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
Affinity DataKi: >5.00E+5nMAssay Description:Inhibitory activity against dengue 2 NS3 protease fused via a linker to region of NS2BMore data for this Ligand-Target Pair
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0160nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6×His-Mcl-1 (171...More data for this Ligand-Target Pair
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0160nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6×His-Mcl-1 (171...More data for this Ligand-Target Pair
TargetInduced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0160nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6× His-Mcl-1 (17...More data for this Ligand-Target Pair
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0160nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6×His-Mcl-1 (171...More data for this Ligand-Target Pair
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0160nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6×His-Mcl-1 (171...More data for this Ligand-Target Pair
TargetInduced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0160nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6× His-Mcl-1 (17...More data for this Ligand-Target Pair
TargetInduced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0180nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6× His-Mcl-1 (17...More data for this Ligand-Target Pair
TargetInduced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0180nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6× His-Mcl-1 (17...More data for this Ligand-Target Pair
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0180nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6×His-Mcl-1 (171...More data for this Ligand-Target Pair
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0180nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6×His-Mcl-1 (171...More data for this Ligand-Target Pair
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0180nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6×His-Mcl-1 (171...More data for this Ligand-Target Pair
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0180nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6×His-Mcl-1 (171...More data for this Ligand-Target Pair
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0190nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6×His-Mcl-1 (171...More data for this Ligand-Target Pair
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0190nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6×His-Mcl-1 (171...More data for this Ligand-Target Pair
TargetInduced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0190nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6× His-Mcl-1 (17...More data for this Ligand-Target Pair
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0200nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6×His-Mcl-1 (171...More data for this Ligand-Target Pair
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0200nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6×His-Mcl-1 (171...More data for this Ligand-Target Pair
TargetInduced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0200nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6× His-Mcl-1 (17...More data for this Ligand-Target Pair
TargetBcl-2-like protein 11 [51-76]/Induced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0220nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6×His-Mcl-1 (171...More data for this Ligand-Target Pair
TargetInduced myeloid leukemia cell differentiation protein Mcl-1 [171-327](Homo sapiens (Human))
Gilead Sciences
US Patent
Gilead Sciences
US Patent
Affinity DataIC50: 0.0220nMAssay Description:The AlphaLISA assay was performed in a 384-well Proxiplate in a total volume of 40 μL. The reaction mixture contained 0.0625 nM 6× His-Mcl-1 (17...More data for this Ligand-Target Pair